نتایج جستجو برای: her 2 receptor

تعداد نتایج: 3013749  

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه اصفهان - دانشکده علوم 1391

گیرنده فاکتور رشد اپیدرمی her-2 به طور مکرر در سرطان پستان و چندین تومور جامد دیگر دچار افزایش بیان می گردد. افزایش بیان ژن her-2 در 10 تا 34% از بیماران سرطان پستان مشاهده شده و بر روی پیشرفت، درمان و تشخیص بیماری موثر است. در نتیجه بررسی صحیح بیان ژن her-2 در سلول های توموری در اداره بیماری و انتخاب صحیح بیمارانی که قادر به درمان با داروهای معمول مانند تراستوزوماب می باشند مهم و ضرورری است. ب...

A. Taghizadeh Kermani H.R. Raziee, K. Ghaffarzadegan M. Taghi Shakeri M.R. Ghavamnasiri

Objective HER-2/neu gene is overexpressed in diverse human cancers and studies suggest a role of its product – p185 protein – in tumor progression by specifically promoting the invasive capacity of tumor cells. Our aim was to evaluate HER-2/neu content in resectable gastric cancer in this geographical region and assess the relationship between p185 expression and clinicopathologic tumor paramet...

Journal: :International Journal of Travel Medicine and Global Health 2015

Journal: :Journal of obstetrics, gynecology and cancer research 2022

Background & Objective: Breast cancer has a pivotal role in many deaths caused by malignancies. Epidermal growth factor receptor-2 (EGFR-2 or HER-2) and estrogen receptor (ER) have immense predictive values as prognostic factors. cancers that steroid receptors respond to hormone therapy show better prognosis than without receptors.Materials Methods: A retrospective cross-sectional study was per...

Journal: :international journal of molecular and cellular medicine 0
atieh zorrieh zahra genetics research center-university of social welfare and rehabilitation sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم بهزیستی و توانبخشی (university of social welfare and rehabilitation sciences) sepideh kadkhoda genetics research center-university of social welfare and rehabilitation sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم بهزیستی و توانبخشی (university of social welfare and rehabilitation sciences) farkhondeh behjati genetics research center-university of social welfare and rehabilitation sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم بهزیستی و توانبخشی (university of social welfare and rehabilitation sciences) fatemeh aghakhani moghaddam genetics research center-university of social welfare and rehabilitation sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم بهزیستی و توانبخشی (university of social welfare and rehabilitation sciences) azadeh badiei genetics research center-university of social welfare and rehabilitation sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم بهزیستی و توانبخشی (university of social welfare and rehabilitation sciences) fereidoon sirati cancer institute- department of surgery- tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)

male breast cancer is a rare disease with an increasing trend. due to limited information especially about the genetic basis of the disease in iran and the lower age of its onset, the disease requires more attention. the aim of this study was to screen the male patients with breast cancer for brca mutations as well as tissue markers of estrogen receptor (er), progesterone receptor (pr), human e...

یادگاری, کیوان, سیرتی, فریدون ,

Breast cancer is the most common site-specific cancer and is the second cause of mortality due to cancer in women. There are different prognostic factors including: axillary nodal status and tumor size(the most important factor), ER activity, PR, tumor grade and the type of histology. Other incompletely defined risk factors are: protease, catepstin, Her-2, etc. Her-2 is subtype 2 of E...

2016
Daniel Sanghoon Shin Timothy Sherry Michael E. Kallen Steven Wong Alexandra Drakaki

CASE 1 A 67-year-old Asian female was diagnosed with locally advanced high-grade salivary duct carcinoma in June 2011. Molecular analysis revealed human epidermal growth factor receptor 2 (HER-2) amplification. She received adjuvant therapy with carboplatin/paclitaxel/ trastuzumab and maintenance of trastuzumab. Upon disease progression, trastuzumab could not be continued due to lack of financi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید